Giełda Transportu

Najnowsze Informacje ze Świata TSL

Świat

Cadila Healthcare inks tech transfer pact with Korean Enzychem Lifesciences

Cadila Healthcare inks tech transfer pact with Korean Enzychem Lifesciences

The pact will lead to production of 80 million or more doses of ZyCoV-D in 2022


Źródło

24 November 2021, 12:04